Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWigg, A.en
dc.contributor.authorNarayana, S.en
dc.contributor.authorAnwar, S.en
dc.contributor.authorRamachandran, J.en
dc.contributor.authorMuller, K.en
dc.contributor.authorChen, J.en
dc.contributor.authorJohn, L.en
dc.contributor.authorHissaria, P.en
dc.contributor.authorKaambwa, B.en
dc.contributor.authorWoodman, R.en
dc.identifier.citationTransplant Infectious Disease, 2019; OnlinePubl(3):e13087en
dc.description.abstractBACKGROUND AND AIMS:Screening for latent tuberculosis infection (LTBI) is recommended prior to solid organ transplantation. Interferon-gamma release assays (IGRAs) are the most widely used test for LTBI screening; however, assessment of IGRA performance in patients with end-stage liver disease is limited. The purpose of this study was to evaluate the prevalence and predictors of indeterminate (INDT) IGRA results in liver transplantation candidates. METHODS:Between March 2011 and May 2018, we retrospectively analyzed 155 patients undergoing liver transplantation assessment, who underwent IGRA testing (Quantiferon-TB Gold, QFT-G) to exclude LTBI. Characteristics of patients, including age, gender, etiology of liver disease, MELD score, and absolute lymphocyte counts, were compared by QFT-G result (determinate vs INDT). RESULTS:Of the 155 patients screened, the rate of positive, negative, and INDT results were 5.2%, 69.8%, and 25%, respectively. The only variable independently associated with an indeterminate test on multivariate analysis was MELD score (odds ratio = 1.07, 95% CI = 1.01-1.14 per unit increase; P = 0.014). In 95% of INDT tests, both TB antigen tube and the positive control tube were negative and repeat testing gave the same indeterminate result, suggestive of anergy rather than laboratory error. CONCLUSIONS:Our study suggests a high rate of INDT IGRA results during screening of liver transplant candidates for LTBI, associated with severity of liver disease and anergy. Because of the high rate of INDT QFT-G testing in this setting, individualized risk assessment is required including a thorough assessment of clinical risk factors and knowledge of local TB prevalence.en
dc.description.statementofresponsibilityAlan J. Wigg, Sumudu K. Narayana, Shahzaib Anwar, Jeyamani Ramachandran, Kate Muller, John W. Chen, Libby John, Pravin Hissaria, Billingsley Kaambwa, Richard J. Woodmanen
dc.publisherJohn Wiley & Sonsen
dc.rights© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltden
dc.subjectanergy; indeterminate; interferon-gamma release assay; latent tuberculosis; liver transplantationen
dc.titleHigh rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidatesen
dc.typeJournal articleen
pubs.library.collectionMedicine publicationsen
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.